Peer-reviewed research and active collaborations advancing multi-omics precision medicine
Our platform is built on scikit-bio, a DOE-funded open-source bioinformatics library trusted by researchers worldwide.
Multi-year collaboration developing microbiome-based biomarkers for infectious disease susceptibility and treatment response prediction.
Joint research on multi-omics integration for cancer immunotherapy response prediction and patient stratification in oncology trials.
Collaborative studies on microbiome-metabolome interactions in autoimmune diseases and therapeutic intervention optimization.